Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized vs Traditional CTV in IMRT for Nasopharyngeal Carcinoma
NCT02627807Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2015
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Local-regional recurrence-free survival rate at 3 years. Status: unknown.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02627807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02627807.